| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 40 |
| 1 | METHOTREXATE | 33 |
| 2 | METHOTREXATE SODIUM | 33 |
| 3 | CYCLOPHOSPHAMIDE | 32 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 32 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 32 |
| 6 | BEVACIZUMAB | 30 |
| 7 | CARBOPLATIN | 26 |
| 8 | TEMOZOLOMIDE | 23 |
| 9 | SOMATROPIN | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOTEPA | 13 | 0.0013 |
| 1 | LOMUSTINE | 3 | 0.0012 |
| 2 | TEMOZOLOMIDE | 23 | 0.0011 |
| 3 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 4 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 5 | TOPOTECAN | 4 | 0.0007 |
| 6 | ETOPOSIDE | 40 | 0.0005 |
| 7 | MELPHALAN HYDROCHLORIDE | 12 | 0.0005 |
| 8 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 9 | FENOFIBRATE | 14 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Growth Hormone [EPC] | 16 | 0.0007 |
| 1 | Topoisomerase Inhibitor [EPC] | 40 | 0.0005 |
| 2 | Hedgehog Pathway Inhibitor [EPC] | 3 | 0.0003 |
| 3 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 14 | 0.0002 |
| 4 | Alkylating Drug [EPC] | 50 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 30 | 0.0002 |
| 6 | Platinum-based Drug [EPC] | 44 | 0.0002 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 34 | 0.0001 |